How Do GLP-1 Drugs Work?

Updated July 2026

GLP-1 medications produce weight loss unlike anything medicine has offered before — and to understand why, and why that weight loss tends to reverse once the drug stops, it helps to know what these drugs actually do inside the body. The reason we needed them in the first place is a story about our food environment. This is the biology.

What is GLP-1?

GLP-1 is a hormone your digestive system releases when you eat. Its full name is glucagon-like peptide-1, and its main job is to steady blood sugar after a meal. It does that largely by prompting the pancreas to release insulin in a measured way, smoothing out the sharp glucose swings that would otherwise follow eating. That blood-sugar effect is what first caught the attention of drug companies looking for better type 2 diabetes treatments.

What are GLP-1 drugs?

They are synthetic, long-acting versions of that natural hormone. Semaglutide — sold as Ozempic and Wegovy — is a lab-made copy of GLP-1, modified to linger in the body long enough to work as a once-a-week injection. Tirzepatide — sold as Mounjaro and Zepbound — does the same and adds a second gut hormone, GIP (glucose-dependent insulinotropic polypeptide), which is why it's called a dual agonist. As both drugs were tested in diabetes trials, something unexpected kept appearing alongside better blood sugar: people were losing a substantial amount of weight. That observation launched this entire category as a weight-loss treatment.

How do GLP-1 medications cause weight loss?

It comes down to a broader set of effects than insulin alone. GLP-1 influences the whole experience of eating, and two of its actions matter most for weight.

The first is that it slows digestion. GLP-1 delays how fast the stomach empties and how quickly food moves through the intestine, so glucose enters the bloodstream more gradually and you feel full longer after a meal.

The second is that it signals the brain. GLP-1 activates neural pathways that register fullness, which quiets appetite and reduces cravings.

Together, slower digestion and a stronger fullness signal sharply reduce the drive to eat, and the weight comes off — commonly around 15 percent of body weight with semaglutide and up to roughly 20 percent with tirzepatide in head-to-head clinical trials, though real-world results are often more modest. Very few weight-loss approaches come close.

Why isn't our own natural GLP-1 enough?

Because the food environment has outmaneuvered it. Our bodies are built to make and release GLP-1 on their own, so the real question is what changed to leave so many of us overweight despite that built-in system. A population-wide genetic collapse in GLP-1 production isn't plausible — evolution doesn't move that fast — so the answer lies in the environment.

Here's where it gets interesting. GLP-1 production is strongly shaped by the makeup of the gut microbiome, and that microbiome is in turn shaped by what we eat. Regular intake of artificial sweeteners, for example, can shift the microbiome and blunt GLP-1 production in as little as two weeks.

Our natural GLP-1 output also assumes we're eating the kind of food the system evolved around — apples, beans, chicken. It isn't equipped for engineered products like Cheetos that are deliberately formulated to scramble those fullness signals. So even normal GLP-1 levels are no match for foods designed to override them. That's why the drugs work: they overwhelm the problem with hormone levels far higher than any meal would produce.

Which points to the real issue. Just as statins lower cholesterol without touching why cholesterol was high to begin with, GLP-1 drugs improve blood sugar and drive weight loss without addressing why blood sugar and weight went off the rails in the first place. They are band-aids, not cures — which is why the weight tends to return when the drug stops, and why what these drugs ask of you over time is worth understanding before starting. The more hopeful implication: if food is what blunted the system, food can also be used to support GLP-1 the way nature intended.

If you're new to this site and found this useful, I write one of these evidence-based articles every week. You can get them in your inbox by joining my email list at the bottom of this page. No spam, no requirement to buy anything, just practical knowledge.